Type and frequency of immune-related adverse reactions in patients treated with Pembrolizumab, a monoclonal antibody directed against PD-1, in advanced melanoma at Mayo Clinic in Jacksonville, Florida (or a single institution?)
other cancers, the alterations to the immune system induced by these medications can trigger immune-related adverse reactions. Documented immune-related adverse reactions of pembrolizumab include pneumonitis…

